Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction have?
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction has 547 citations in the OpenAlex counts ScholarIQ stores.
When was Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction published?
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction has 2015 year in the ScholarIQ index.
What is the open-access status of Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction?
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction has gold oa status in the ScholarIQ index.
What is the DOI of Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction?
The DOI for Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction is on the source record.
What is the PMID of Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction?
The PMID for Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction is on the source record.
What is the OpenAlex record for Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction?
The OpenAlex for Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction is on the source record.